FinancialsFinancial Services
  • Price (USD)20.00
  • Today's Change0.16 / 0.81%
  • Shares traded3.87m
  • 1 Year change-9.26%
  • Beta1.0196
Data delayed at least 15 minutes, as of Sep 22 2021 21:10 BST.
More ▼
Take Survey
Help shape our future virtual events & community services
Take part in our survey for a chance to win a free 3-month standard gift subscription.

Profile data is unavailable for this security.

About the company

The Western Union Company (Western Union) is a provider of money movement and payment services. The Company operates through two segments: Consumer-to-Consumer and Business Solutions. The Company's Consumer-to-Consumer segment facilitates money transfers between two consumers, primarily through a network of third-party agents. The Company's multi-currency, real-time money transfer services are viewed by the Company as one interconnected network where a money transfer can be sent from one location to another, around the world. Western Union's Business Solutions segment facilitates payment and foreign exchange solutions, primarily cross-border, cross-currency transactions, for small and medium size enterprises and individuals. Business Solutions payment transactions are conducted through various channels, including the phone and via the Internet.

  • Revenue in USD (TTM)5.03bn
  • Net income in USD810.00m
  • Incorporated2006
  • Employees11.00k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Terminix Global Holdings Inc2.00bn59.00m5.53bn11.40k96.262.2133.302.760.46074.2515.2520.020.404226.809.69175,614.001.110.80471.270.947541.7644.592.752.031.253.950.25930.00-5.58-5.44-84.50-34.19-8.25--
Cerevel Therapeutics Holdings Inc0.00-252.26m5.63bn104.00--16.87-----2.82-2.820.002.300.00----0.00-94.49---99.96--------------0.0989--------------
ManpowerGroup Inc.19.84bn260.10m5.78bn25.00k23.072.4217.310.29124.624.62348.7044.022.21--4.21793,648.002.904.525.789.1115.8916.341.311.90--15.970.313332.57-13.72-1.41-94.89-43.66-0.61957.15
AbCellera Biologics Inc-100.00bn-100.00bn5.88bn206.00--6.03----------3.49------------------------12.37--0.0018--1,907.96--5,479.20------
R1 RCM Inc1.33bn-512.10m5.95bn19.00k--18.47--4.47-2.12-,084.2111.047.2513.659.8519.4122.269.615.50--8.980.62610.007.1461.06644.83--18.30--
TriNet Group Inc4.20bn247.00m6.24bn2.70k25.678.3819.071.493.693.6962.8911.301.45--11.811,554,815.008.557.0418.4419.1518.5818.015.884.94--19.650.39950.004.628.6928.3053.7113.63--
Nielsen Holdings PLC4.96bn234.00m6.92bn43.00k29.682.307.231.400.65031.9213.818.410.3943--6.05115,325.601.93-0.35542.18-0.4160.8057.254.90-0.8483--3.190.6468---3.200.379598.55--4.93-26.11
Sarepta Therapeutics Inc600.08m-634.47m7.00bn866.00--14.42--11.66-8.03-8.037.586.080.21270.35365.18692,935.30-22.49-28.55-26.10-32.5786.7988.30-105.73-141.044.70-5.670.6926--41.82236.4422.51--76.25--
Sotera Health Co880.94m9.03m7.16bn3.00k520.3613.6845.108.130.04860.04863.071.850.325711.927.82293,646.000.4038--0.4272--55.31--1.24--2.462.010.7816--5.12---85.21------
WEX Inc1.65bn-336.46m7.36bn5.30k--4.10409.984.46-7.60-7.6037.2140.070.1928--0.6851311,574.70-2.900.4835-4.290.70261.1861.46-15.032.32--2.350.60320.00-9.5012.79-346.08--4.85--
Taskus Inc-100.00bn-100.00bn7.42bn23.60k------------------------------------------------32.91--1.75------
Fiverr International Ltd251.81m-39.67m7.48bn545.00--21.22--29.71-1.12-,042.20-6.10---7.86--83.13---15.76-----1.920.5134--76.99--56.66------
Western Union Co5.03bn810.00m8.06bn11.00k10.1328.207.831.601.961.9612.160.70340.5688----457,272.709.166.9811.398.6041.8840.4716.1012.01--9.530.912852.95-8.64-2.49-29.67-2.34-9.407.74
Biohaven Pharmaceutical Holding Co Ltd189.53m-888.51m8.80bn825.00------46.44-14.40-14.403.07-6.960.29841.221.78229,738.20-140.34-150.01-275.36-196.0576.57---470.22-2,717.501.51-5.972.11-------45.01--580.78--
Genpact Ltd3.82bn354.39m9.02bn96.50k26.324.9017.812.361.831.8319.679.820.7841--4.2139,588.487.277.899.8210.3935.7836.489.289.22--10.950.482416.885.368.551.115.155.27--
Booz Allen Hamilton Holding Corporation7.89bn568.39m10.55bn28.60k18.9810.3315.921.344.114.1157.167.561.48--4.94284,893.5010.7010.2514.1514.4353.4853.887.245.99--8.550.735731.535.297.7725.8515.825.5319.21
Data as of Sep 22 2021. Currency figures normalised to Western Union Co's reporting currency: US Dollar USD

Institutional shareholders

49.74%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Jun 202146.26m11.38%
BlackRock Fund Advisorsas of 30 Jun 202139.76m9.79%
Capital Research & Management Co. (Global Investors)as of 30 Jun 202121.06m5.18%
SSgA Funds Management, Inc.as of 30 Jun 202120.92m5.15%
Independent Franchise Partners LLPas of 30 Jun 202120.20m4.97%
Fidelity Management & Research Co. LLCas of 30 Jun 202118.28m4.50%
Goldman Sachs Asset Management LPas of 30 Jun 202110.57m2.60%
Clarkston Capital Partners LLCas of 30 Jun 20219.18m2.26%
Geode Capital Management LLCas of 30 Jun 20218.19m2.02%
LSV Asset Managementas of 30 Jun 20217.68m1.89%
More ▼
Data from 30 Jun 2021 - 30 Jun 2021Source: FactSet Research Systems Inc.
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.